Traders should monitor the upcoming earnings call for revenue, EPS, and guidance updates, particularly given the company's small market cap of $36M, which can make it sensitive to performance shifts.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 11 $0.7800entry
- T+1 · 8mo ago −1.03%α +0.46% · $0.7720
- T+5 · 8mo ago −7.69%α −5.50% · $0.7200
- T+20 · 7mo ago −23.59%α −24.11% · $0.5960
- T+60 · 6mo ago +10.26%α −1.27% · $0.8600
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
TELA Bio announced it will report its fourth quarter and full year 2025 financial results on March 24, 2026, followed by a conference call. No financial data was released in this press release, it is purely a scheduling announcement.
Key Facts
- TELA Bio will report Q4 and full year 2025 financial results on March 24, 2026.
- Management will host a conference call and webcast at 4:30 p.m. ET on that day.
- No financial results or guidance were disclosed in this release.
- This is a routine earnings announcement press release with no material financial data.
Financial Impact
None at this time, actual financials will be disclosed on March 24, 2026.
Risk Factors
- High volatility risk around earnings due to low market cap and lack of current financial disclosure.
- Forward-looking statements in the release are speculative and not indicative of actual performance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3253309 |
Track record
20 reports on TELA
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +18.61% at T+5 after the Aug 10, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $0.7610 Now $0.7620 +0.13% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.8200 Now $0.7620 −7.07% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.8201 Now $0.7620 −7.08% settles Nov 23
- Nov 10, 20266d ago S-3 Bearish 5/10 Entry $0.9418 Now $0.7620 +19.09% settles Nov 18
- Nov 10, 20266d ago Press Release Bearish 5/10 Entry $0.9418 Now $0.7620 +19.09% settles Nov 18
- Oct 27, 202620d ago Press Release Neutral 2/10 Entry $0.9760 to $0.8378 Now $0.7620 −21.93% ▼ −14.16% −13.45% vs SPY
- Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.07 to $1.10 Now $0.7620 −28.79% ▲ +2.34% +3.32% vs SPY
- Oct 5, 20266w ago 8-K Bullish 5/10 Entry $1.14 to $1.08 Now $0.7620 −33.16% ▼ −5.26% −5.69% vs SPY
- Aug 31, 202611w ago 8-K Mixed 6/10 Entry $0.7380 to $0.8301 Now $0.7620 +3.25% ▲ +12.48% +12.62% vs SPY
- Aug 10, 202614w ago 8-K Bearish 7/10 Entry $0.7900 to $0.6430 Now $0.7620 +3.54% ▲ +18.61% +18.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers